Trichoblastic carcinoma: a comprehensive review of the literature

Arch Dermatol Res. 2022 Jul;314(5):399-403. doi: 10.1007/s00403-021-02241-y. Epub 2021 May 15.

Abstract

Trichoblastic carcinoma is a rare neoplasm thought to arise from malignant degeneration of benign follicular tumors. Its clinical features, optimal treatment, and outcomes remain largely unknown. We performed a comprehensive review of the existing trichoblastic carcinoma literature. PubMed and Google Scholar were searched for keywords related to trichoblastic carcinoma, and additional articles were found in reference lists. Cases with a histopathologic diagnosis of trichoblastic carcinoma were summarized. A total of 93 cases have been described, all in case reports or case series. The average age was 65, with 66.7% of cases in males. A minority of patients had familial tumor syndromes or a history of radiation at the site, and only one was reported to be immunosuppressed. The most common site was the face (48.4%), and the majority developed de novo (87.1%). The clinical presentation was highly variable. Although most cases (82.8%) were successfully treated with surgery alone, a subset of patients had more aggressive disease including local progression or recurrence in five cases, nodal metastases in five cases, and distant metastases in three cases. Trichoblastic carcinoma is a rare malignancy with the potential for aggressive behavior. Further research is needed to better characterize this neoplasm.

Keywords: Adnexal neoplasms; Follicular neoplasms; Malignant trichoblastoma; Trichoblastic carcinoma.

Publication types

  • Review

MeSH terms

  • Aged
  • Carcinoma* / pathology
  • Face / pathology
  • Hair Diseases* / diagnosis
  • Hair Diseases* / pathology
  • Hair Diseases* / therapy
  • Humans
  • Male
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / therapy